lumen glp 1 Should you track your metabolism with Lumen? GLP-1 receptor assay: drug discovery

#GLP1 #WeightLossDrugs #PharmaRegulation #DrugPolicy #IndianPharma #HealthcarePolicy #ObesityTreatment #PharmaIndustry #DrugMarketing #ETPharma #HealthcareNews #LifeSciences

While he notes Novo Nordisk's pill as "important" to consumers, it's Eli Lilly's injectable he sees continuing to lead GLP-1 momentum

The obesity epidemic in Henderson is on the rise due to unhealthy eating habits, lack of physical activity, and genetics

PlexusDx GLP-1 medications qualify for HSA and FSA payment, making compounded semaglutide and tirzepatide more accessible

Read the full press release.

Empower is a major 503A/503B compounder offering semaglutide and tirzepatide nationwide, but its record includes repeated FDA scrutiny.